Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Sep;39(9):2827-2828.
doi: 10.1007/s10067-020-05118-z. Epub 2020 May 18.

Full histological and clinical regression of morphea with tofacitinib

Morton Scheinberg  1 , Cid Sabbagh  2 , Sineida Ferreira  2 , Nilceo Michalany  2
Affiliations
Editorial

Full histological and clinical regression of morphea with tofacitinib

Morton Scheinberg et al. Clin Rheumatol. 2020 Sep.
No abstract available

PubMed Disclaimer

References

    1. Hurabielle C, Sicre de Fontbrune F, Moins-Teisserenc H, Robin M, Jachiet M, Coman T, Dhedin N, Cassius C, Chasset F, de Masson A, Michonneau D, Bagot M, Bergeron A, Socié G, Peffault de Latour R, Bouaziz JD (2017) Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease. Br J Dermatol 177:e206–e208 - DOI
    1. Kim SR, Charos A, King BA (2018) Treatment of generalized morphea and eosinophilic fasciitis with the Janus Kinase Inhibitor Tofacitinib. JAAD Case Rep 4:443–445 - DOI
    1. Wang W, Bhattacharyya S, Marangoni RG, Carns M, Dennis-Aren K, Yeldandi A, Wei J, Varga J (2019) The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib. J Scleroderma Relat Disord 5:40–50 - DOI
    1. Jaller JA, Jaller JJ, Jaller AM, Jaller-Char JJ, Ferreira SB, Ferreira R, Scheinberg M (2017) Recovery of nail dystrophy potential new therapeutic indication of tofacitinib. Clin Rheumatol 36:971–973 - DOI
    1. Scheinberg M, de Lucena Couto Océa RA, Cruz BA, Ferreira SB (2017) Brazilian experience of the treatment of alopecia universalis with the novel antirheumatic therapy tofacitinib: A Case Series. Rheumatol Ther 4:503–509 - DOI

Publication types

LinkOut - more resources